Home › ABBOTT VASCULAR INC. › ABSORB GT1
ABSORB GT1
ABBOTT VASCULAR INC. · Model 1235250-08 · UDI-DI 08717648212932
PNY
Prescription
0
510(k) clearances
929
Adverse events (110 deaths)
1
Recalls
3
Facilities
Description
Absorb GT1 Bioresorbable Vascular Scaffold System 2.50 mm x 8 mm / Rapid-Exchange
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2017-04-26 | Abbott Vascular | Abbott Vascular is initiating a recall of the Absorb Bioresorbable Vascular Scaffold (BVS) System due to studies showing elevated rates of major adverse events, specifically, myoca |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.